Brandon Brown

934 total citations · 1 hit paper
13 papers, 727 citations indexed

About

Brandon Brown is a scholar working on Pathology and Forensic Medicine, Hematology and Molecular Biology. According to data from OpenAlex, Brandon Brown has authored 13 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 4 papers in Hematology and 2 papers in Molecular Biology. Recurrent topics in Brandon Brown's work include Multiple Sclerosis Research Studies (7 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Peripheral Neuropathies and Disorders (2 papers). Brandon Brown is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Peripheral Neuropathies and Disorders (2 papers). Brandon Brown collaborates with scholars based in United States, Switzerland and Mexico. Brandon Brown's co-authors include Jeffrey L. Schnipper, Jennifer L. Kirwin, Sylvia C. McKean, Mark S. Horng, Christopher L. Roy, Michael Cotugno, Allen Kachalia, David W. Bates, Jamie L. Weiss and Xiangyi Meng and has published in prestigious journals such as Neurology, Drug Safety and Annals of Pharmacotherapy.

In The Last Decade

Brandon Brown

12 papers receiving 684 citations

Hit Papers

Role of Pharmacist Counseling in Preventing Adverse Drug ... 2006 2026 2012 2019 2006 200 400 600

Peers

Brandon Brown
Cynthia A. Sanoski United States
Kent Nelson United States
Joy Meier United States
Donald G. Pittman United States
Amanda J. Cross Australia
Brandon Brown
Citations per year, relative to Brandon Brown Brandon Brown (= 1×) peers Dan Henrohn

Countries citing papers authored by Brandon Brown

Since Specialization
Citations

This map shows the geographic impact of Brandon Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Brown more than expected).

Fields of papers citing papers by Brandon Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Brown. The network helps show where Brandon Brown may publish in the future.

Co-authorship network of co-authors of Brandon Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon Brown. A scholar is included among the top collaborators of Brandon Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon Brown. Brandon Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Amin, Moein, Harvey M. Tucker, Brandon Brown, et al.. (2025). Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practice. Neurodegenerative Disease Management. 15(1). 27–36. 3 indexed citations
2.
Brown, Brandon, et al.. (2025). Real-world change in annualized relapse rate and healthcare resource utilization following initiation of ofatumumab in people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 102. 106617–106617. 1 indexed citations
3.
Hersh, Carrie M., et al.. (2024). Real-world persistence and adherence of ofatumumab versus oral and injectable disease-modifying therapies in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 91. 105888–105888. 2 indexed citations
6.
Brown, Brandon, et al.. (2019). Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic. BMC Neurology. 19(1). 287–287. 11 indexed citations
7.
Enns, Russell, et al.. (2016). Maneuver and Mission Aiding via Tactile Cueing Flight Demonstrations. 1–15. 1 indexed citations
10.
Brown, Brandon, et al.. (2010). Incidence of Infusion-Associated Reactions with Rituximab for Treating Multiple Sclerosis. Drug Safety. 34(2). 117–123. 26 indexed citations
11.
Brown, Brandon. (2009). Natalizumab in the treatment of multiple sclerosis. Therapeutics and Clinical Risk Management. 5(3). 585–585. 22 indexed citations
12.
Brown, Brandon, et al.. (2007). Fingolimod: A Novel Immunosuppressant for Multiple Sclerosis. Annals of Pharmacotherapy. 41(10). 1660–1668. 32 indexed citations
13.
Schnipper, Jeffrey L., Jennifer L. Kirwin, Michael Cotugno, et al.. (2006). Role of Pharmacist Counseling in Preventing Adverse Drug Events After Hospitalization. Archives of Internal Medicine. 166(5). 565–565. 626 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026